How Novartis’ For-Profit Social Business Is Reshaping Healthcare
Executive Summary
Amid glaring healthcare gaps in emerging markets like India, Novartis has scaled up its unique for-profit social business; similar initiatives are running in Kenya and Vietnam. Scrip brings you an on the ground report from rural India, where the Swiss multinational is trying to make a difference in a sustainable way.
You may also be interested in...
Novartis India MD On Scalable Digital Solutions, Balancing Work-Life Mix Amid COVID-19
Novartis India chief outlines how the company is navigating the challenging business environment amid the coronavirus pandemic, including for its for-profit social business. Digital solutions are a key part of these efforts and the executive offers advice for those struggling to balance the work-life mix in these testing times.
USAID Alliance Opens New Funding Vistas For Healthcare Providers In India
The US Agency for International Development (USAID) is shepherding novel approaches to improve access to capital for healthcare providers in emerging markets like India. Its initiative with a leading housing finance company, DHFL, hopes to improve healthcare for India’s urban poor.
How Sanofi Is ‘Playing To Win’ In India, Watch Diabetes Space
Sanofi India managing director Rodolfo Hrosz talks to Scrip about the company’s refreshed India strategy including in the competitive diabetes segment, which is expected to see a flurry of new product activity. While Soliqua has hit the market, all eyes are also on Novo Nordisk’s Awiqli and Cipla’s partnered inhaled insulin in the wings.